Insider Transactions in Q4 2022 at Dia Medica Therapeutics Inc. (DMAC)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2022
|
Randall Michael Giuffre Director |
BUY
Open market or private purchase
|
Direct |
37,079
+12.47%
|
$37,079
$1.43 P/Share
|
|
Dec 08
2022
|
Randall Michael Giuffre Director |
BUY
Open market or private purchase
|
Direct |
20,000
+8.23%
|
$20,000
$1.4 P/Share
|
|
Dec 07
2022
|
Randall Michael Giuffre Director |
BUY
Open market or private purchase
|
Direct |
22,574
+10.0%
|
$22,574
$1.4 P/Share
|
|
Dec 06
2022
|
Randall Michael Giuffre Director |
BUY
Open market or private purchase
|
Direct |
2,300
+1.26%
|
$2,300
$1.35 P/Share
|
|
Dec 05
2022
|
Richard D. Pilnik Director |
BUY
Open market or private purchase
|
Direct |
35,000
+18.49%
|
$35,000
$1.39 P/Share
|
|
Dec 02
2022
|
Thomas Von Koch > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,855,847
+50.0%
|
$2,855,847
$1.24 P/Share
|
|
Dec 02
2022
|
Thomas Von Koch > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,855,847
-100.0%
|
$2,855,847
$1.24 P/Share
|
|
Dec 01
2022
|
Randall Michael Giuffre Director |
BUY
Open market or private purchase
|
Direct |
46,952
+10.55%
|
$46,952
$1.2 P/Share
|
|
Nov 30
2022
|
Randall Michael Giuffre Director |
BUY
Open market or private purchase
|
Direct |
2,970
+2.21%
|
$2,970
$1.19 P/Share
|
|
Nov 29
2022
|
Randall Michael Giuffre Director |
BUY
Open market or private purchase
|
Direct |
18,125
+12.37%
|
$18,125
$1.19 P/Share
|
|
Nov 16
2022
|
Dietrich John Pauls President and CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+26.38%
|
$20,000
$1.21 P/Share
|